Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group patent vasopressin receptor antagonists

June 21, 2022

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

June 21, 2022

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

June 21, 2022

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

June 20, 2022

Anti-glypican-3 antibody-drug conjugates developed at Ardeagen

June 20, 2022

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

June 20, 2022

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

New MRGPRX2 antagonists identified at Bioardis

June 20, 2022

BioWorld MedTech Patent Highlights: Week 23

From Current Patent Gazette

June 17, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Gossamer Bio presents Janus kinase inhibitors

June 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...